Ignite Creation Date:
2024-05-06 @ 12:13 PM
Last Modification Date:
2024-10-26 @ 12:56 PM
Study NCT ID:
NCT03707808
Status:
COMPLETED
Last Update Posted:
2020-12-29
First Post:
2018-02-05
Brief Title:
Intratumoral Injection of Autologous CD1c BDCA-1 myDC Avelumab and Ipilimumab Plus Systemic Nivolumab
Sponsor:
Universitair Ziekenhuis Brussel
Organization:
Universitair Ziekenhuis Brussel
Organization Data
Organization:
Universitair Ziekenhuis Brussel
Class:
OTHER
Study ID:
2017-BN-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Universitair Ziekenhuis Brussel
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None